US Experience in Evaluation and Diagnosis of GH Therapy of Intrauterine Growth Retardation/Small-for-Gestational-Age Children
- 1 November 2002
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 58 (Suppl. 3) , 27-29
- https://doi.org/10.1159/000066479
Abstract
The potential role of exogenous GH in treating short children born small for gestational age (SGA) has been discussed since the early 1960s. Pivotal studies in Europe during the last 10 years have shown that GH treatment of short children born SGA during childhood and early puberty (1) normalizes stature, (2) increases final height above predicted height and (3) allows children to reach their target height. A study now under way in the USA will provide additional much needed data about efficacy and safety of GH treatment in intrauterine growth retardation/SGA.Keywords
This publication has 6 references indexed in Scilit:
- Growth Hormone Treatment of Short Children Born Small for Gestational Age: Growth Responses with Continuous and Discontinuous Regimens Over 6 YearsJournal of Clinical Endocrinology & Metabolism, 2000
- Growth Hormone Treatment in Children with Short Stature Born Small for Gestational Age: 5-Year Results of a Randomized, Double-Blind, Dose-Response TrialJournal of Clinical Endocrinology & Metabolism, 1999
- Growth Hormone Treatment in Growth Hormone-Sufficient and -Insufficient Children with Intrauterine Growth Retardation/Russell-Silver SyndromeHormone Research in Paediatrics, 1998
- EditorialEuropean Journal of Clinical Nutrition, 1998
- High-dose growth hormone treatment of short children born small for gestational ageJournal of Clinical Endocrinology & Metabolism, 1996
- Clinical review 68: The endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factorsJournal of Clinical Endocrinology & Metabolism, 1995